[Percutaneous transluminal valvuloplasty of a stenosed and calcified aortic valve in the aged]

Related Experiment Videos

Insights

Percutaneous balloon valvuloplasty effectively reduced aortic pressure gradients in a patient with calcific aortic stenosis. The procedure was safe and did not worsen aortic regurgitation, offering a viable treatment option.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Calcific aortic stenosis is a common valvular heart disease in the elderly, leading to significant hemodynamic compromise.
  • Percutaneous balloon valvuloplasty (PBV) is a less invasive option for aortic stenosis management, particularly in high-risk patients.

Observation:

  • A 76-year-old female presented with symptomatic calcific aortic stenosis.
  • The patient had pre-existing mild aortic regurgitation prior to the intervention.

Findings:

  • Percutaneous balloon valvuloplasty successfully reduced the transvalvular aortic gradient from 80 mm Hg to 40 mm Hg.
  • Aortic regurgitation did not increase post-procedure.
  • The valvuloplasty was performed without complications, and the patient was discharged within one week.

Implications:

  • Balloon valvuloplasty can be an effective and safe palliative treatment for severe aortic stenosis, improving hemodynamic status.
  • This case highlights the potential benefit of PBV in selected elderly patients, preserving quality of life and avoiding immediate surgical intervention.

Related Concept Videos